Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kobayashi Pharmaceutical CoKBYPF -2.71%81 Interest Coverage is 265.20 as of Dec. 2025, which is 70% below its 10-year median of 888.64. GuruFocus rates KBYPF with a GF Score™ of 81/100 and a GF Value™ of $35.48. The stock has 5 warning signs investors should review. Among 1,516 Consumer Packaged Goods companies, Kobayashi Pharmaceutical Co ranks better than 91.89% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Kobayashi Pharmaceutical Co's
Operating Income
for the
three
months ended in Dec. 2025 was $22 Mil. Kobayashi Pharmaceutical Co's Interest Expense for the
three
months ended in Dec. 2025 was $-0 Mil.
Kobayashi Pharmaceutical Co's interest coverage for the quarter that ended in Dec. 2025 was 265.20.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Kobayashi Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Kobayashi Pharmaceutical Co's Interest Coverage or its related term are showing as below:
KBYPF'
s Interest Coverage Range Over the Past 10 Years
Min: 490.86 Med: 888.64 Max: 1481.89
Current: 490.86
KBYPF's Interest Coverage is ranked better than 91.89% of 1516
companies
in the Consumer Packaged Goods industry
Industry Median: 8.605
vs KBYPF: 490.86
Kobayashi Pharmaceutical Co (OTCPK:KBYPF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Kobayashi Pharmaceutical Co Interest Coverage Related Terms
Kobayashi Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Kobayashi Pharmaceutical Co Interest Coverage Chart
KBYPF vs PG, CL, KVUE: Interest Coverage Comparison
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's Interest Coverage falls into.
Kobayashi Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co (KBYPF) has a Interest Coverage of 265.20 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kobayashi Pharmaceutical Co and its competitors. This is 70% below median its historical median of 888.64. Over the past decade, Kobayashi Pharmaceutical Co's Interest Coverage has ranged from 490.86 to 1,481.89. According to the industry distribution chart, Kobayashi Pharmaceutical Co ranks #123 out of 1516 companies in the Consumer Packaged Goods industry, placing it in the top 8.1%.
Is Kobayashi Pharmaceutical Co's Interest Coverage too high?
Kobayashi Pharmaceutical Co's current Interest Coverage of 265.20 is 70% below median its 10-year median of 888.64. Over the past 10 years, this metric has ranged from a low of 490.86 to a high of 1,481.89. The Consumer Packaged Goods industry median Interest Coverage is 8.61. Kobayashi Pharmaceutical Co's value of 265.20 is 2981.9% above this industry median. Based on the distribution chart, Kobayashi Pharmaceutical Co ranks #123 out of 1516 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Interest Coverage compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kobayashi Pharmaceutical Co ranks #123 out of 1516 companies for Interest Coverage. This places Kobayashi Pharmaceutical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 8.61. Kobayashi Pharmaceutical Co's value of 265.20 is 2981.9% above this benchmark. Historically, Kobayashi Pharmaceutical Co's own Interest Coverage has ranged from 490.86 to 1,481.89 over the past decade. While the company's 10-year median is 888.64 vs. the industry median of 8.61, Kobayashi Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.61, based on 1,516 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kobayashi Pharmaceutical Co's current Interest Coverage of 265.20 is 2981.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kobayashi Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kobayashi Pharmaceutical Co's current Interest Coverage is 265.20, which is 70% below median its own 10-year median of 888.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (KBYPF) has a current Interest Coverage of 265.20. The stock's GF Value™ is $35.48, compared to a current price of $34.05 — trading 4% below its estimated fair value. The current Interest Coverage is 265.20, which is 70% below median its 10-year median of 888.64 and 2981.9% above the Consumer Packaged Goods industry median of 8.61. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (KBYPF), the current Interest Coverage is 265.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (KBYPF) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of $34.05 is trading 4% below its estimated GF Value™ of $35.48.
Key valuation signals for KBYPF:
Interest Coverage: 265.20 (70% below median its 10-year median of 888.64)
GF Value™: $35.48 vs. price of $34.05 (4% below fair value)
Industry Position: 2981.9% above the Consumer Packaged Goods median (#123 of 1516)
No single metric tells the full story. See the KBYPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for KBYPF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KBYPF has been successfully added to your 
